179 related articles for article (PubMed ID: 38506875)
1. [Application of biologicals in patients with food allergies].
Agar Muñoz AM; Galván Calle CA
Rev Alerg Mex; 2023 Dec; 70(4):297-299. PubMed ID: 38506875
[TBL] [Abstract][Full Text] [Related]
2. New biologics for food allergy.
Schuetz JP; Anderson B; Sindher SB
Curr Opin Allergy Clin Immunol; 2024 Jun; 24(3):147-152. PubMed ID: 38547423
[TBL] [Abstract][Full Text] [Related]
3. Biologics in food allergy: up-to-date.
Passanisi S; Caminiti L; Zirilli G; Lombardo F; Crisafulli G; Aversa T; Pajno GB
Expert Opin Biol Ther; 2021 Sep; 21(9):1227-1235. PubMed ID: 33733975
[No Abstract] [Full Text] [Related]
4. The use of biologics in food allergy.
Fiocchi A; Vickery BP; Wood RA
Clin Exp Allergy; 2021 Aug; 51(8):1006-1018. PubMed ID: 33966304
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma.
Agache I; Beltran J; Akdis C; Akdis M; Canelo-Aybar C; Canonica GW; Casale T; Chivato T; Corren J; Del Giacco S; Eiwegger T; Firinu D; Gern JE; Hamelmann E; Hanania N; Mäkelä M; Hernández-Martín I; Nair P; O'Mahony L; Papadopoulos NG; Papi A; Park HS; Pérez de Llano L; Posso M; Rocha C; Quirce S; Sastre J; Shamji M; Song Y; Steiner C; Schwarze J; Alonso-Coello P; Palomares O; Jutel M
Allergy; 2020 May; 75(5):1023-1042. PubMed ID: 32034960
[TBL] [Abstract][Full Text] [Related]
6. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Webster KE; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013513. PubMed ID: 33710614
[TBL] [Abstract][Full Text] [Related]
7. Combining Anti-IgE Monoclonal Antibodies and Oral Immunotherapy for the Treatment of Food Allergy.
Guilleminault L; Michelet M; Reber LL
Clin Rev Allergy Immunol; 2022 Feb; 62(1):216-231. PubMed ID: 34550555
[TBL] [Abstract][Full Text] [Related]
8. Biologics in allergic rhinitis.
Bayar Muluk N; Cingi C
Eur Rev Med Pharmacol Sci; 2023 Oct; 27(5 Suppl):43-52. PubMed ID: 37869947
[TBL] [Abstract][Full Text] [Related]
9. The Role of Biologics in the Treatment of Food Allergy.
Sindher SB; Fiocchi A; Zuberbier T; Arasi S; Wood RA; Chinthrajah RS
J Allergy Clin Immunol Pract; 2024 Mar; 12(3):562-568. PubMed ID: 38013157
[TBL] [Abstract][Full Text] [Related]
10. Biologics for the Treatment of Food Allergies.
Brar KK; Lanser BJ; Schneider A; Nowak-Wegrzyn A
Immunol Allergy Clin North Am; 2020 Nov; 40(4):575-591. PubMed ID: 33012321
[TBL] [Abstract][Full Text] [Related]
11. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
12. Biologics and Novel Therapies for Food Allergy.
Albuhairi S; Rachid R
Immunol Allergy Clin North Am; 2021 May; 41(2):271-283. PubMed ID: 33863483
[TBL] [Abstract][Full Text] [Related]
13. Role of biologics in severe food allergy.
Dinardo G; Cafarotti A; Fierro V; Artesani MC; Indolfi C; Miraglia Del Giudice M; Fiocchi A
Curr Opin Allergy Clin Immunol; 2024 Jun; 24(3):138-143. PubMed ID: 38538153
[TBL] [Abstract][Full Text] [Related]
14. Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial.
Andorf S; Purington N; Block WM; Long AJ; Tupa D; Brittain E; Rudman Spergel A; Desai M; Galli SJ; Nadeau KC; Chinthrajah RS
Lancet Gastroenterol Hepatol; 2018 Feb; 3(2):85-94. PubMed ID: 29242014
[TBL] [Abstract][Full Text] [Related]
15. Omalizumab in children with severe allergic disease: a case series.
Crisafulli G; Caminiti L; Chiera F; Arasi S; Salzano G; Panasiti I; Barbalace A; Pajno GB
Ital J Pediatr; 2019 Jan; 45(1):13. PubMed ID: 30642367
[TBL] [Abstract][Full Text] [Related]
16. Use of biologics in severe food allergies.
Fiocchi A; Pecora V; Valluzzi RL; Fierro V; Mennini M
Curr Opin Allergy Clin Immunol; 2017 Jun; 17(3):232-238. PubMed ID: 28375933
[TBL] [Abstract][Full Text] [Related]
17. Enhancing the Safety and Efficacy of Food Allergy Immunotherapy: a Review of Adjunctive Therapies.
Virkud YV; Wang J; Shreffler WG
Clin Rev Allergy Immunol; 2018 Oct; 55(2):172-189. PubMed ID: 29968170
[TBL] [Abstract][Full Text] [Related]
18. Biological Therapies for Eosinophilic Esophagitis: Where Do We Stand?
Ko E; Chehade M
Clin Rev Allergy Immunol; 2018 Oct; 55(2):205-216. PubMed ID: 29372536
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in the treatment of eosinophilic esophagitis and food allergy.
Rocha R; Vitor AB; Trindade E; Lima R; Tavares M; Lopes J; Dias JA
Eur J Pediatr; 2011 Nov; 170(11):1471-4. PubMed ID: 21809010
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal Antibodies for Treatment of Eosinophilic Esophagitis.
Eskian M; Khorasanizadeh M; Assa'ad AH; Rezaei N
Clin Rev Allergy Immunol; 2018 Aug; 55(1):88-98. PubMed ID: 29234969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
